- Home
- DXPE vs IMCR Comparison
DXPE vs IMCR Comparison
Compare DXPE & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXPE
- IMCR
- Stock Information
- Founded
- DXPE 1908
- IMCR 2008
- Country
- DXPE United States
- IMCR United Kingdom
- Employees
- DXPE N/A
- IMCR N/A
- Industry
- DXPE Industrial Machinery/Components
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DXPE Industrials
- IMCR Health Care
- Exchange
- DXPE Nasdaq
- IMCR Nasdaq
- Market Cap
- DXPE 1.4B
- IMCR 1.5B
- IPO Year
- DXPE 1996
- IMCR 2021
- Fundamental
- Price
- DXPE $84.71
- IMCR $28.40
- Analyst Decision
- DXPE Buy
- IMCR Buy
- Analyst Count
- DXPE 1
- IMCR 11
- Target Price
- DXPE $95.00
- IMCR $59.11
- AVG Volume (30 Days)
- DXPE 97.6K
- IMCR 259.4K
- Earning Date
- DXPE 05-07-2025
- IMCR 05-07-2025
- Dividend Yield
- DXPE N/A
- IMCR N/A
- EPS Growth
- DXPE 33.22
- IMCR N/A
- EPS
- DXPE 4.81
- IMCR N/A
- Revenue
- DXPE $1,865,974,000.00
- IMCR $333,581,000.00
- Revenue This Year
- DXPE $12.04
- IMCR $20.26
- Revenue Next Year
- DXPE $3.62
- IMCR $8.49
- P/E Ratio
- DXPE $17.66
- IMCR N/A
- Revenue Growth
- DXPE 11.94
- IMCR 25.75
- 52 Week Low
- DXPE $43.25
- IMCR $23.15
- 52 Week High
- DXPE $107.06
- IMCR $62.22
- Technical
- Relative Strength Index (RSI)
- DXPE 48.70
- IMCR 45.68
- Support Level
- DXPE $76.21
- IMCR $27.88
- Resistance Level
- DXPE $94.68
- IMCR $31.38
- Average True Range (ATR)
- DXPE 4.27
- IMCR 1.60
- MACD
- DXPE 0.25
- IMCR -0.08
- Stochastic Oscillator
- DXPE 46.02
- IMCR 22.19
About DXPE DXP Enterprises Inc.
DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating, and production services for rotating equipment, bearings, power transmissions, industrial supplies, and safety products. It serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Others.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.